EG23929A - Isoxazolines derivatives and their use as antidepressants - Google Patents

Isoxazolines derivatives and their use as antidepressants

Info

Publication number
EG23929A
EG23929A EG20020197A EG20020197A EG23929A EG 23929 A EG23929 A EG 23929A EG 20020197 A EG20020197 A EG 20020197A EG 20020197 A EG20020197 A EG 20020197A EG 23929 A EG23929 A EG 23929A
Authority
EG
Egypt
Prior art keywords
antidepressants
isoxazolines
derivatives
isoxazolines derivatives
Prior art date
Application number
EG20020197A
Other languages
English (en)
Inventor
Jose I Andres-Gil
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG23929A publication Critical patent/EG23929A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
EG20020197A 2001-02-21 2002-02-19 Isoxazolines derivatives and their use as antidepressants EG23929A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05

Publications (1)

Publication Number Publication Date
EG23929A true EG23929A (en) 2008-01-14

Family

ID=26076836

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20020197A EG23929A (en) 2001-02-21 2002-02-19 Isoxazolines derivatives and their use as antidepressants

Country Status (32)

Country Link
US (1) US7169786B2 (pl)
EP (1) EP1368358B1 (pl)
JP (1) JP3953424B2 (pl)
KR (1) KR100848898B1 (pl)
CN (1) CN100400540C (pl)
AR (1) AR035685A1 (pl)
AT (1) ATE337322T1 (pl)
AU (1) AU2002244717B2 (pl)
BG (1) BG107984A (pl)
BR (1) BR0207433A (pl)
CA (1) CA2437505C (pl)
CY (1) CY1106448T1 (pl)
CZ (1) CZ20032515A3 (pl)
DE (1) DE60214138T2 (pl)
DK (1) DK1368358T3 (pl)
EA (1) EA006747B1 (pl)
EE (1) EE200300398A (pl)
EG (1) EG23929A (pl)
ES (1) ES2271230T3 (pl)
HR (1) HRP20030647A2 (pl)
HU (1) HUP0303270A3 (pl)
IL (2) IL157470A0 (pl)
MX (1) MXPA03007432A (pl)
MY (1) MY137836A (pl)
NO (1) NO20033700L (pl)
NZ (1) NZ526741A (pl)
PL (1) PL208593B1 (pl)
PT (1) PT1368358E (pl)
SI (1) SI1368358T1 (pl)
SK (1) SK11612003A3 (pl)
TW (1) TWI257392B (pl)
WO (1) WO2002066484A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
KR20040093061A (ko) * 2002-04-02 2004-11-04 얀센 파마슈티카 엔.브이. 치환된 아미노 이속사졸린 유도체 및 항-우울제로서의그의 용도
TW200409777A (en) 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
DE60331160D1 (de) * 2002-08-15 2010-03-18 Janssen Pharmaceutica Nv Kondensierte heterocyclische isoxazolinderivate und deren verwendung als antidepressiva
EP1532155B1 (en) * 2002-08-21 2008-02-27 Janssen Pharmaceutica N.V. C6- AND C9-SUBSTITUTED CHROMENO[4,3-c]ISOXAZOLINE DERIVATIVES AND THEIR USE AS ANTI-DEPRESSANTS
WO2004078715A1 (ja) * 2003-03-07 2004-09-16 Astellas Pharma Inc. 2,6-ジ置換スチリルを有する含窒素へテロ環誘導体
CN103788089A (zh) 2003-09-17 2014-05-14 詹森药业有限公司 作为血清素受体调节剂的稠合杂环化合物
EP1944306A1 (en) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fused heterocyclic compounds as serotonin receptor modulators
CA2585857A1 (en) * 2004-11-26 2006-06-01 Janssen Pharmaceutica N.V. Isoxazoline-indole derivatives with an improved antipsychotic and anxiolytic activity
NZ579431A (en) * 2007-03-09 2012-04-27 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
MX2009013205A (es) * 2007-06-08 2010-04-09 Helicon Therapeutics Inc Derivados de pirazoloquinolina urea terapeuticos.
WO2009082268A2 (ru) 2007-12-21 2009-07-02 Alla Chem, Llc ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361577B1 (en) * 1988-09-19 1993-05-05 Akzo N.V. Tetrahydronaphthalene and indane derivatives
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
PT892804E (pt) * 1996-04-12 2003-01-31 Janssen Pharmaceutica Nv Derivados de isoxazolidina
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
EP1119568B1 (en) * 1998-10-09 2004-02-18 Janssen Pharmaceutica N.V. 4,5-dihydro-isoxazole derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
EP1368358B1 (en) 2006-08-23
SK11612003A3 (sk) 2004-04-06
CZ20032515A3 (cs) 2003-12-17
TWI257392B (en) 2006-07-01
ES2271230T3 (es) 2007-04-16
CN100400540C (zh) 2008-07-09
HK1065537A1 (zh) 2005-02-25
EA200300915A1 (ru) 2004-06-24
EA006747B1 (ru) 2006-04-28
NO20033700D0 (no) 2003-08-20
CN1492871A (zh) 2004-04-28
PL208593B1 (pl) 2011-05-31
EE200300398A (et) 2003-12-15
IL157470A0 (en) 2004-03-28
MXPA03007432A (es) 2003-11-18
DE60214138T2 (de) 2007-03-29
US20040122037A1 (en) 2004-06-24
PL363264A1 (pl) 2004-11-15
PT1368358E (pt) 2007-01-31
NO20033700L (no) 2003-10-21
JP2004518748A (ja) 2004-06-24
KR100848898B1 (ko) 2008-07-29
EP1368358A1 (en) 2003-12-10
ATE337322T1 (de) 2006-09-15
MY137836A (en) 2009-03-31
AU2002244717B2 (en) 2007-07-19
KR20030076590A (ko) 2003-09-26
BG107984A (bg) 2004-09-30
SI1368358T1 (sl) 2007-02-28
NZ526741A (en) 2004-04-30
DE60214138D1 (de) 2006-10-05
HUP0303270A3 (en) 2007-03-28
US7169786B2 (en) 2007-01-30
CY1106448T1 (el) 2011-10-12
DK1368358T3 (da) 2007-01-02
IL157470A (en) 2008-07-08
JP3953424B2 (ja) 2007-08-08
HUP0303270A2 (hu) 2004-01-28
HRP20030647A2 (en) 2005-06-30
CA2437505C (en) 2010-02-09
WO2002066484A1 (en) 2002-08-29
BR0207433A (pt) 2004-06-01
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29

Similar Documents

Publication Publication Date Title
IL162266A (en) Substituted 2-thio-3,5-dicyano-4- phenyl-6-aminopyridines and the use of the same
PT1757606E (pt) Utilização de derivados de xantina como produto farmacêutico, bem como seu processo de preparação
SI1427711T1 (sl) Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
EP1367060A4 (en) GLUCOPYRANOSYLOXYBENZYLBENZENE DERIVATIVES AND THEIR MEDICAL USE
EP1364957A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND THEIR MEDICAL USE
PL375764A1 (pl) Indazole, benzotiazole i benzoizotiazole, sposób ich wytwarzania oraz ich zastosowanie
EP1364958A4 (en) GLYCOPYRANOSYLOXYPYRAZOLE DERIVATIVES AND MEDICINAL USE THEREOF
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
HUP0401335A3 (en) Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof
HUP0300268A3 (en) Herbicidal benzoylpyrazole derivatives, compositions containing the same and their use
DE60208622D1 (de) Siliciumoxidpulver und dessen Herstellung
HUP0402489A3 (en) 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
IL155520A0 (en) Benzoxazinone derivatives, their preparation and use
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
IL166821A0 (en) Novel 1,4-diazabicycloalkane derivatives their preparation and use
HUP0401092A3 (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
MXPA03001826A (es) Derivados de arilpiperazina.
SI1532141T1 (sl) 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi
HUP0600238A3 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
IL156794A0 (en) Chemical derivatives and their use as anti-telomerase agent
GB0200843D0 (en) Benzodioxinopyrroles their preparation and use